Vext Science, Inc. Stock

Equities

VEXT

CA9255401064

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange 03:32:23 2024-04-26 pm EDT 5-day change 1st Jan Change
0.24 CAD +2.13% Intraday chart for Vext Science, Inc. 0.00% -17.24%
Sales 2023 * 35.38M 48.36M Sales 2024 * 47.74M 65.25M Capitalization 43.03M 58.82M
Net income 2023 * - Net income 2024 * - EV / Sales 2023 * 2.01 x
Net Debt 2023 * 28.1M 38.41M Net Debt 2024 * 40.3M 55.09M EV / Sales 2024 * 1.75 x
P/E ratio 2023 *
-12 x
P/E ratio 2024 *
-12 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 31.17%
More Fundamentals * Assessed data
Dynamic Chart
Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive Role CI
Vext Science, Inc. Announces Board Changes CI
Transcript : Vext Science, Inc., Q3 2023 Earnings Call, Nov 28, 2023
Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (VEXTF) VEXT SCIENCE Reports Q3 Revenue $8.1M MT
Elevate Cannabis Co. completed the acquisition of Cultivation facility located in Prescott Valley, Arizona of Vext Science, Inc.. CI
Elevate Cannabis Co. entered into an agreement to acquire Cultivation facility located in Prescott Valley, Arizona of Vext Science, Inc. for $6.5 million. CI
Vext Science, Inc. announced that it has received $10 million in funding from LLF Financial S.A. CI
Vext Science Agrees to Buy 2 Additional Ohio Retail Locations; Plans Concurrent Private Placement; Down 13% MT
Vext Science, Inc. signed a letter of intent to acquire two cannabis dispensaries in Ohio from Big Perm?s DispensaryOhio, LLC for approximately $9.8 million. CI
Vext Science, Inc. announced that it expects to receive CAD 10 million in funding CI
Transcript : Vext Science, Inc., Q2 2023 Earnings Call, Aug 23, 2023
Vext Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Vext Science, Inc. Announces CFO Changes CI
Vext Science, Inc. Resigns Stephan Bankosz as Corporate Secretary, Effective August 25, 2023 CI
More news
1 day+2.13%
Current month-14.29%
1 month-14.29%
3 months-32.39%
6 months-17.24%
Current year-17.24%
More quotes
1 week
0.23
Extreme 0.23
0.25
1 month
0.23
Extreme 0.23
0.29
Current year
0.22
Extreme 0.215
0.42
1 year
0.20
Extreme 0.2
0.42
3 years
0.19
Extreme 0.185
1.06
5 years
0.19
Extreme 0.185
2.10
10 years
0.19
Extreme 0.185
2.10
More quotes
Managers TitleAgeSince
Founder 43 15-12-10
Chief Executive Officer - 17-12-31
Director of Finance/CFO - 23-08-24
Members of the board TitleAgeSince
Director/Board Member 67 22-02-09
Director/Board Member 62 17-01-31
Director/Board Member - 18-11-30
More insiders
Date Price Change Volume
24-04-26 0.24 +2.13% 18,000
24-04-25 0.235 -2.08% 39,504
24-04-23 0.24 -2.04% 19,500
24-04-22 0.245 +2.08% 38,520
24-04-19 0.24 -2.04% 24,000

Delayed Quote Canadian Securities Exchange, April 26, 2024 at 03:32 pm EDT

More quotes
Vext Science, Inc. is a cannabis operator. The Company’s expertise spans from cultivation through to retail operations in markets of Arizona and Ohio. It manufactures THC cartridges, concentrates, edibles and accessories under the Vapen brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen CBD and Herbal Wellness brands. It has THC concentrates, edibles, and distillate cartridge brands sold in various states dispensaries. It owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. Additionally, it provides management, advisory, cultivation, and dispensary services to entities in the cannabis field through joint operations agreements. It also sells CBD products and branded merchandise. Vapen Brands product is the wholesale product and sold in its dispensaries. Vapen Brand is an edible and concentrate brand. The Company also owns cannabis dispensary in Columbus, Ohio.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.24 CAD
Average target price
0.7333 CAD
Spread / Average Target
+205.55%
Consensus